COPD (chronic obstructive pulmonary disease), lung diseases, asthma bronchitis ...
How
- Improve your symptoms in COPD and other lung diseases, smoker's lung, asthma or bronchitis,
- reduces your consumption of medicines
- can improve your quality of life,
read here!
AIRVI therapy is particularly successful in COPD and other lung diseases or asthma. The oxygen of the surrounding air is processed in the AIRVI therapy devices according to the natural model of photosynthesis. If the natural air of the AIRVI therapy devices is regularly inhaled through light breathing goggles, the lungs will benefit from a better metabolism. This natural oxygen-energy therapy
- helps the lungs to reactivate their self-healing powers,
- reduces harmful oxygen radicals, which, as is well known, are caused more often by the breathing of concentrated oxygen,
- Exhaustion and listlessness improve with regular AIRVI breathing,
- the quality of life improves significantly,
- the progression of the disease is usually stopped and usually even regressed.
Users of the AIRVI SET Oxygen Energy Therapy repeatedly report an increased quality of life and more well-being. This applies to COPD as well as to pulmonary emphysema, chronic cough, chronic bronchitis, chronic asthma, shortness of breath or any other lung disease.
What does chronic obstructive pulmonary disease (COPD) mean for people with the disease?
Chronic obstructive pulmonary disease (COPD) is characterized by:
- chronic cough
- increased ejection
- shortness of breath
The consequences are:
- the decreased oxygen uptake in the blood via the lung cells,
- the reduced energy production in the cells (mitochondria = energy power plants of the cells), accompanied by a lack of physical performance,
- Over-inflation of the alveoli (pulmonary alveoli) with reduced gas exchange,
- the repeated formation of mucus, which must be removed by coughing,
- the noticeable reduction of the quality of life and various restrictions in daily life,
- the perspective that the disease is progressive and not curable.
Further consequences of COPD include:
- heart failure
- heart conditions
- pulmonary failure
- Isolation/Depression
It is estimated that 3 to 5 million people in Germany, about 400,000 in Switzerland and about 600 million worldwide are affected by COPD and thus comes to the realistic assumption that COPD assumes the dimension of a widespread disease and will be the third leading cause of death by 2020